Now that global regulators have approved four oral solid-dosage drugs that were made using continuous processes two from Vertex (in 2015 and 2018), one from Janssen (in 2016), and one from Eli Lilly (in 2017) equipment manufacturers and early adopters are working to resolve engineering challengeOriginal Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.